NCT06554795 2026-03-19
First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors
DualityBio Inc.
Phase 1/2 Recruiting
Clinical Trials
9 trialsNCT00571389 2026-03-18
A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.
BioCytics, Inc.
Recruiting
NCT05223608 2026-03-18
ImmuCCo
Centre Oscar Lambret
Phase NA Recruiting
NCT05689853 2026-03-18
Study of AK119 Combined With AK112 in Patients With Advanced Solid Tumors
Akeso
Phase 1/2 Recruiting
NCT04928508 2026-03-05
Okgyn1
University of Oklahoma
Phase 1 Recruiting
NCT04219254 2026-02-25
A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
BioInvent International AB
Phase 1/2 Recruiting
NCT06265688 2026-02-20
First In Human Study of CX-2051 in Advanced Solid Tumors
CytomX Therapeutics
Phase 1 Recruiting
NCT06397963 2026-01-26
Autologous Tumor-Infiltrating Lymphocyte (GT307 Injection ) for Treatment of Patients With Solid Tumours
Grit Biotechnology
Phase NA Recruiting
NCT06265727 2026-01-08
A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors
Corbus Pharmaceuticals Inc.
Phase 1/2 Recruiting